ADAG·Nasdaq·US
Adagene
Adagene is a clinical-stage biotechnology company focused on engineered antibody therapeutics built on its SAFEbody masking platform. Its lead programs, including ADG126 and ADG116, are being developed for solid tumors, and the company also monetizes the platform through strategic collaborations such as its partnership with Sanofi.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.